Literature DB >> 33716968

Alternative RNA Splicing in Fatty Liver Disease.

Panyisha Wu1, Moya Zhang2, Nicholas J G Webster3,1,4.   

Abstract

Alternative RNA splicing is a process by which introns are removed and exons are assembled to construct different RNA transcript isoforms from a single pre-mRNA. Previous studies have demonstrated an association between dysregulation of RNA splicing and a number of clinical syndromes, but the generality to common disease has not been established. Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease affecting one-third of adults worldwide, increasing the risk of cirrhosis and hepatocellular carcinoma (HCC). In this review we focus on the change in alternative RNA splicing in fatty liver disease and the role for splicing regulation in disease progression.
Copyright © 2021 Wu, Zhang and Webster.

Entities:  

Keywords:  NAFLD; NASH; RNA splicing; cirrhosis; splicing factor

Mesh:

Year:  2021        PMID: 33716968      PMCID: PMC7953061          DOI: 10.3389/fendo.2021.613213

Source DB:  PubMed          Journal:  Front Endocrinol (Lausanne)        ISSN: 1664-2392            Impact factor:   5.555


  158 in total

1.  The splicing factors 9G8 and SRp20 transactivate splicing through different and specific enhancers.

Authors:  Y Cavaloc; C F Bourgeois; L Kister; J Stévenin
Journal:  RNA       Date:  1999-03       Impact factor: 4.942

Review 2.  Splicing alterations contributing to cancer hallmarks in the liver: central role of dedifferentiation and genome instability.

Authors:  Maddalen Jimenez; María Arechederra; Matías A Ávila; Carmen Berasain
Journal:  Transl Gastroenterol Hepatol       Date:  2018-10-31

Review 3.  RNA Splicing and Disease: Animal Models to Therapies.

Authors:  Matías Montes; Brianne L Sanford; Daniel F Comiskey; Dawn S Chandler
Journal:  Trends Genet       Date:  2018-11-19       Impact factor: 11.639

4.  Altered hepatic gene expression in nonalcoholic fatty liver disease is associated with lower hepatic n-3 and n-6 polyunsaturated fatty acids.

Authors:  Bianca M Arendt; Elena M Comelli; David W L Ma; Wendy Lou; Anastasia Teterina; TaeHyung Kim; Scott K Fung; David K H Wong; Ian McGilvray; Sandra E Fischer; Johane P Allard
Journal:  Hepatology       Date:  2015-02-27       Impact factor: 17.425

5.  Up-regulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in the liver of obese diabetic mice.

Authors:  R A Memon; L H Tecott; K Nonogaki; A Beigneux; A H Moser; C Grunfeld; K R Feingold
Journal:  Endocrinology       Date:  2000-11       Impact factor: 4.736

6.  Tissue-specific expression of two alternatively spliced insulin receptor mRNAs in man.

Authors:  D E Moller; A Yokota; J F Caro; J S Flier
Journal:  Mol Endocrinol       Date:  1989-08

7.  c-Myc is a target of RNA-binding motif protein 15 in the regulation of adult hematopoietic stem cell and megakaryocyte development.

Authors:  Chao Niu; Jiwang Zhang; Peter Breslin; Mihaela Onciu; Zhigui Ma; Stephan Wade Morris
Journal:  Blood       Date:  2009-06-19       Impact factor: 22.113

8.  Comparison of Gene Expression Patterns Between Mouse Models of Nonalcoholic Fatty Liver Disease and Liver Tissues From Patients.

Authors:  Andreas Teufel; Timo Itzel; Wiebke Erhart; Mario Brosch; Xiao Yu Wang; Yong Ook Kim; Witigo von Schönfels; Alexander Herrmann; Stefan Brückner; Felix Stickel; Jean-François Dufour; Triantafyllos Chavakis; Claus Hellerbrand; Rainer Spang; Thorsten Maass; Thomas Becker; Stefan Schreiber; Clemens Schafmayer; Detlef Schuppan; Jochen Hampe
Journal:  Gastroenterology       Date:  2016-06-16       Impact factor: 22.682

9.  Ductular Reaction Cells Display an Inflammatory Profile and Recruit Neutrophils in Alcoholic Hepatitis.

Authors:  Beatriz Aguilar-Bravo; Daniel Rodrigo-Torres; Silvia Ariño; Mar Coll; Elisa Pose; Delia Blaya; Isabel Graupera; Luis Perea; Júlia Vallverdú; Teresa Rubio-Tomás; Laurent Dubuquoy; Carolina Armengol; Antonio Lo Nigro; Peter Stärkel; Philippe Mathurin; Ramon Bataller; Joan Caballería; Juan José Lozano; Pere Ginès; Pau Sancho-Bru
Journal:  Hepatology       Date:  2019-03-12       Impact factor: 17.298

View more
  2 in total

1.  Lipin 1 modulates mRNA splicing during fasting adaptation in liver.

Authors:  Huan Wang; Tracey W Chan; Ajay A Vashisht; Brian G Drew; Anna C Calkin; Thurl E Harris; James A Wohlschlegel; Xinshu Xiao; Karen Reue
Journal:  JCI Insight       Date:  2021-09-08

Review 2.  Pharmacotherapy for Non-Alcoholic Fatty Liver Disease: Emerging Targets and Drug Candidates.

Authors:  Veronika A Prikhodko; Natalia N Bezborodkina; Sergey V Okovityi
Journal:  Biomedicines       Date:  2022-01-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.